214 completed, 90 unknown, 41 recruiting, 18 active not recruiting. 145 Not applicable, 52 Phase 2, 38 Phase 3, 22 Phase 4, 14 Phase 1.
Follow Ludwig-Maximilians - University of Munich: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN) Semaglutide (SEMA), Exercise module, Anti-inflammatory diet module - Severe Mental Illness, Depression / Major Depressive Disorder | Not applicable | Not yet recruiting | Ludwig-Maximilians - University of Munich | 140 | 2028-10-01 | 2026-05-14 |
| Stratification and Treatment in Early Psychosis Study -ASSIST CBD 100 mg/mL Oral Solution, Placeb - Treatment Resistant Psychosis, Psychosis | Phase 3 | Not yet recruiting | University of Oxford | 250 | 2027-01-01 | 2026-10-08 |
| Stratification and Treatment in Early Psychosis Study - ENHANCE CBD 100 mg/mL Oral Solution, Placebo - Psychosis, First Episode Psychosis | Phase 3 | Recruiting | University of Oxford | 250 | 2026-10-05 | 2026-10-08 |
| Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD) Dornase Alfa, Isotonic Saline Solution - Ischemic Stroke, Inflammatory Response | Phase 2 | Recruiting | Ludwig-Maximilians - University of Munich | 36 | 2026-10-01 | 2026-09-11 |
| ICF-Based Interdisciplinary Case Management for Individuals With Disabilities ICF-Based Interdisciplinary Case Management (Rehab-Cycle®), Conventional Care Management - Intellectual Disability, Mild to Moderate, Developmental Disability | Not applicable | Recruiting | The Hong Kong Polytechnic University | 120 | 2026-10-01 | 2026-09-10 |
| HoLEP-ThuLEP - Comparing Lasers for BPH Surgery Thulium Laser Enucleation of the Prostate (ThuLEP), Holmium Laser Enucleation of the Prostate (HoLEP) - BPH (Benign Prostatic Hyperplasia) | Not applicable | Recruiting | Ludwig-Maximilians - University of Munich | 150 | 2026-09-05 | 2026-10-07 |
| REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder Tumors CURTIS retrieval device - Bladder Cancer, Bladder Cancer TNM Staging Primary Tumor (T) T1 | Not applicable | Not yet recruiting | Ludwig-Maximilians - University of Munich | 75 | 2026-09-01 | 2026-08-17 |
| A Longitudinal Natural History Study of OPA1-Associated Autosomal-Dominant Optic Atrophy OPA1 Gene Mutation, Optic Atrophy, Autosomal Dominant | Recruiting | Ludwig-Maximilians - University of Munich | 50 | 2026-07-16 | 2026-07-28 | |
| Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory Metastases Radiotherapy to the prostate and to PSMA-PET positive metastases - Prostate Cancer, Prostate Cancer Metastatic Disease | Not applicable | Not yet recruiting | University Hospital Tuebingen | 27 | 2026-07-01 | 2026-06-12 |
| Evaluation of a Structured Nutrition Educational Program Among Patients With Type 2 Diabetes Nutrition intervention - Type 2 Diabetes | Not applicable | Active not recruiting | Cho Ray Hospital | 253 | 2026-06-08 | 2026-10-22 |
| FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis FEEL GOOD, Treatment as Usual (TAU) - Delusional Disorder, Brief Psychotic Disorder | Not applicable | Recruiting | Stephanie Mehl | 252 | 2026-05-27 | 2026-09-22 |
| Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promote Early-stage Disease Detection and Personalized/Precision Care Using Innovative Research Platforms CVD, Type 2 Diabetes | Not yet recruiting | The University of Hong Kong | 15000 | 2026-05-01 | 2026-05-06 | |
| COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P) PSMA-11 - Intermediate-risk Prostate Cancer, High-risk Prostate Cancer | Active not recruiting | Heinrich-Heine University, Duesseldorf | 600 | 2026-01-01 | 2026-03-06 | |
| Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy Prostate Cancer (Diagnosis), Prostate Cancer Patients Who Have Brachytherapy Seed Implant | Recruiting | University of Erlangen-Nürnberg Medical School | 200 | 2025-12-01 | 2025-11-18 | |
| Adaptation and Validation of a Patient-centered Outcome Scale for People in the Intensive Care Unit (IPOS-ICU) IPOS-ICU - Intensive Care Unit Patients | Not yet recruiting | Heinrich-Heine University, Duesseldorf | 500 | 2025-11-01 | 2025-06-04 | |
| Decision-making, Ethical Consent, and Interactive Dialogue in Ongoing Neurocognitive Decline - DECISION Alzheimer Disease, Neurodegenerative Diseases | Active not recruiting | Ludwig-Maximilians - University of Munich | 100 | 2025-10-02 | 2026-04-16 | |
| Spatiotemporal Associations Between the COVID-19 Pandemic and Cancer Diagnoses in Bavaria Cancer | Active not recruiting | Bavarian Cancer Registry | 438000 | 2025-09-03 | 2026-01-06 | |
| Assessment of Daily Stressors in Children With Depressive Symptoms for the Development of a Gamified Emotion Regulation App Depressive Disorder, Depression in Children | Recruiting | Ludwig-Maximilians - University of Munich | 15 | 2025-09-02 | 2025-09-08 | |
| Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly Mild Cognitive Impairment, Mild Dementia | Recruiting | Ludwig-Maximilians - University of Munich | 1020 | 2025-07-01 | 2026-04-01 | |
| A Qualitative Analysis of Youth Responses to Depression Education Delivered on Social Media "ich bin alles" (English: "I am everything") - Depressive Disorder, Depression - Major Depressive Disorder | Completed | Ludwig-Maximilians - University of Munich | 18 | 2025-06-01 | 2025-12-04 |
Showing 20 of 396. Sign in to see all of them.
Depression (20) · Schizophrenia (16) · COVID-19 (13) · Diabetes Mellitus (12) · Depressive Disorder (11) · Ischemic Stroke (11) · Depressive Disorder, Major (10) · Neoplasms (10) · Psychotic Disorders (10) · Stroke (10) · Alzheimer Disease (9) · Tuberculosis (9) · Psychological Well-Being (8) · Breast Neoplasms (7) · Colorectal Neoplasms (7)
Fluorouracil (9) · Gemcitabine (8) · Irinotecan (8) · Leucovorin (6) · Oxaliplatin (6) · Bevacizumab (5) · Capecitabine (5) · Therapeutics (5) · exendin (9-39) (5) · Cetuximab (4) · Cognitive Behavioral Therapy (4) · Sodium Chloride (4) · Transcranial Direct Current Stimulation (4) · Acetylcysteine (3) · Carboplatin (3)
Germany (318) · Netherlands (18) · United Kingdom (17) · Spain (16) · Italy (15) · Switzerland (14) · Austria (12) · Belgium (10) · France (9) · Israel (8) · Tanzania (8) · United States (7) · Greece (6) · Norway (6) · Poland (6)
Berthold Koletzko, Prof. (9) · Joerg Schirra, MD (5) · Falk Roeder, MD (4) · Martin Dichgans, Prof. (4) · Bernhard Zwissler, Prof.Dr.med. (3) · Daniel Teupser, Prof.Dr.med. (3) · Marylyn M Addo, MD (3) · Michael Vogeser, Prof.Dr.med. (3) · Oliver Pogarell, MD (3) · Robert Perneczky, Prof. Dr. (3) · Sebastian F Baumbach, MD (3) · Volker Heinemann, PhD, MD (3) · Anette-G. Ziegler, Prof. Dr., MD (2)
PMID 39749328, PMID 42348024, PMID 10368877, PMID 10725531, PMID 11114689, PMID 11710893, PMID 11739431, PMID 12457625, PMID 12459649, PMID 12540795, PMID 12639223, PMID 14571231, PMID 15284112, PMID 16554525, PMID 16946304, PMID 17289576, PMID 17490978, PMID 17996212, PMID 18316457, PMID 18455424, PMID 19132267, PMID 19146917, PMID 19303675, PMID 19341510, PMID 19386747, PMID 19388861, PMID 19445426, PMID 19602953, PMID 20205964, PMID 20233955, PMID 20308616, PMID 20420756, PMID 20673559, PMID 20975325, PMID 21159164, PMID 21163927, PMID 21397413, PMID 21525247, PMID 21849596, PMID 21849603, PMID 21861888, PMID 21918213, PMID 21959915, PMID 22008957, PMID 22075649, PMID 22089446, PMID 22481281, PMID 22596155, PMID 22608065, PMID 22624879
2014 (4), 2005 (3), 2008 (3), 2017 (2), 2019 (2), 2023 (2), 2025 (2), 2015 (1), 2018 (1)